Get the Stockscreener App
93.02
1.13%
1.04
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $93.02, with a volume of 6.45M.
It is up +1.13% in the last 24 hours and up +4.26% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$91.98
Open:
$92.52
24h Volume:
6.45M
Relative Volume:
0.85
Market Cap:
$119.23B
Revenue:
$33.54B
Net Income/Loss:
$4.69B
P/E Ratio:
25.70
EPS:
3.62
Net Cash Flow:
$5.19B
1W Performance:
+0.15%
1M Performance:
+4.26%
6M Performance:
+0.23%
1Y Performance:
+11.20%
1-Day Range:
$92.02
$93.18
1-Week Range:
$91.45
$93.28
52-Week Range:
$79.29
$96.25
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
93.02 | 117.85B | 33.54B | 4.69B | 5.19B | 3.62 |
|
ABT
Abbott Laboratories
|
131.75 | 225.01B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.17 | 154.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
381.91 | 144.71B | 23.82B | 2.92B | 4.02B | 7.55 |
|
EW
Edwards Lifesciences Corp
|
78.26 | 45.90B | 5.69B | 1.41B | 577.90M | 6.95 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Medtronic (MDT) Maintains Hold Rating from Needham Analyst Michael Matson - AInvest
Medtronic announces cash dividend for second quarter of fiscal year 2026 - The Malaysian Reserve
Medtronic (MDT) Declares US$0.71 Dividend Confirming 48 Years Of Increases - uk.finance.yahoo.com
Medtronic recommends affected customers to remove certain left heart vent catheters from use, says FDA - MarketScreener
Medtronic Set To Outperform As Tariff Worries Ease - Finimize
Medtronic Likely to Top Fiscal First-Quarter Estimates, Raise Full-Year Outlook, Needham Says - MarketScreener
TD Cowen Adjusts Price Target on Medtronic to $106 From $95, Maintains Buy Rating - MarketScreener
Needham reiterates Hold rating on Medtronic stock ahead of earnings By Investing.com - Investing.com Australia
How to recover losses in Medtronic plc stockJuly 2025 Outlook & Fast Entry High Yield Tips - Newser
Medtronic : announces 2025 American College of Cardiology / American Heart Association updated hypertension guidelines for renal denervation; procedure now recommended - MarketScreener
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Medtronic announces cash dividend for second quarter of fiscal year 2026 | MDT Stock News - GuruFocus
Medtronic Keeps Quarterly Dividend at $0.71 a Share, Payable Oct. 17 to Holders of Record Sept. 26 - MarketScreener
Medtronic declares $0.71 quarterly dividend for fiscal 2026 By Investing.com - Investing.com Canada
Insights Into Medtronic (MDT) Q1: Wall Street Projections for Key Metrics - sharewise.com
Medical tech giant Medtronic extends 48-year dividend growth streak with $0.71 payout - Stock Titan
Does Medtronic’s (MDT) AI Ambitions Signal a Transformative Shift or Just Incremental Innovation? - simplywall.st
Precision Trading with Medtronic Plc. (MDT) Risk Zones - news.stocktradersdaily.com
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Medtronic Plc (MDT) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com
MDT Stock Trades Cheaper Than Peers Ahead of Q1 Earnings: Time to Buy? - The Globe and Mail
Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk - Yahoo Finance
Former Medtronic Supply Chain Leader Joins FourKites' Strategic Advisory Council - Yahoo Finance
Sentiment analysis tools applied to Medtronic plcWeekly Volume Report & Verified Stock Trade Ideas - Newser
Earnings visualization tools for Medtronic plc [Portfolio Return Summary]Free Weekly High Return Stock Forecasts - Newser
Medtronic gets EU nod for MiniMed 780G System - MSN
Wireless Surgical Cameras Market Rewriting Long Term Growth Story | Medtronic, Aesculap, Ecleris - newstrail.com
Ranking Medtronic plc among high performing stocks via toolsSupport and Resistance Zone Summary Chart - Newser
Is This a Bottoming Phase for Medtronic plcCapital Preserving Trade Plan Templates Shared - metal.it
Can Medtronic plc weather a recessionHigh Growth Alert System - kangso.co.kr
Daily Turnover | The turnover of Medtronic on 8/8 was $612.96 Million, Ranking 149 - AInvest
Medtronic PLC Shares Surge on Strong Market Performance - thekhabrilal
Neuro-Navigation Systems Market Set to Witness Significant Growth by 2025-2032 | Medtronic plc, Stryker - EIN News
Medtronic Bets On Growth And Focus With Diabetes Spin-Off - Finimize
Are Wall Street Analysts Bullish on Medtronic Stock? - MSN
Medtronic (MDT) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Medtronic to Report Q1 FY2026 Results Eyes Momentum in Global Markets - MSN
Medtronic (MDT) Stock Growth & Analyst Outlook 2024News and Statistics - IndexBox
Medtronic Stock Analyst Sentiment: Analysts Bullish on MDT Despite Recent Surge - AInvest
Are Wall Street Analysts Bullish On Medtronic Stock? - Barchart.com
Medtronic and Father Muller Medical College join forces to enhance surgical training in Laparoscopic and H ... - Mangalorean.com
Those who invested in Medtronic (NYSE:MDT) a year ago are up 15% - simplywall.st
Medtronic, FMMC join forces to enhance surgical training in laparoscopic, hernia procedures - Daijiworld
Medtronic to Report Q1 FY2026 Results, Eyes Momentum in Global MarketsVietnam Investment Review - Vietnam Investment Review - VIR
Medtronic to announce financial results for its first quarter of fiscal year 2026 - Laotian Times
Medtronic Announces Q1 FY 2026 Earnings on August 19, 2025 - AInvest
Why Medtronic (MDT) is Poised to Beat Earnings Estimates Again - Yahoo Finance
United States Smart Pills Market Research and Company Analysis Report 2025-2033 Featuring Check-Cap, General Electric, Fujifilm, Koninklijke Philips, Medtronic, Olympus, Novartis, Otsuka - Yahoo Finance
Bernstein Adjusts Price Target on Medtronic to $97 From $93, Maintains Outperform Rating - MarketScreener
Medtronic (MDT) Invests in Orchestra BioMed's Strategic Expansion - GuruFocus
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):